Teachers Retirement System of The State of Kentucky Has $1.52 Million Stock Holdings in The Clorox Company (NYSE:CLX)

Teachers Retirement System of The State of Kentucky trimmed its position in The Clorox Company (NYSE:CLXFree Report) by 4.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,622 shares of the company’s stock after selling 488 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in Clorox were worth $1,515,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CLX. Rafferty Asset Management LLC grew its holdings in Clorox by 11.2% in the 3rd quarter. Rafferty Asset Management LLC now owns 9,231 shares of the company’s stock valued at $1,210,000 after buying an additional 929 shares in the last quarter. Envestnet Asset Management Inc. grew its holdings in Clorox by 27.2% in the 3rd quarter. Envestnet Asset Management Inc. now owns 260,276 shares of the company’s stock valued at $34,112,000 after buying an additional 55,620 shares in the last quarter. LPL Financial LLC grew its holdings in Clorox by 1.5% in the 3rd quarter. LPL Financial LLC now owns 276,835 shares of the company’s stock valued at $36,282,000 after buying an additional 4,035 shares in the last quarter. Mariner LLC grew its holdings in Clorox by 19.1% in the 3rd quarter. Mariner LLC now owns 94,412 shares of the company’s stock valued at $12,374,000 after buying an additional 15,112 shares in the last quarter. Finally, Federated Hermes Inc. lifted its position in shares of Clorox by 16.4% during the 3rd quarter. Federated Hermes Inc. now owns 4,744 shares of the company’s stock valued at $622,000 after acquiring an additional 670 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have recently weighed in on CLX. Evercore ISI cut their target price on Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research report on Wednesday, May 1st. Argus upgraded Clorox to a “hold” rating in a research report on Tuesday, June 4th. The Goldman Sachs Group began coverage on Clorox in a research report on Friday, March 1st. They set a “sell” rating and a $140.00 target price for the company. DA Davidson reiterated a “neutral” rating and set a $162.00 target price on shares of Clorox in a research report on Wednesday, April 17th. Finally, Citigroup cut their target price on Clorox from $155.00 to $150.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Four investment analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the stock. According to data from MarketBeat, Clorox presently has a consensus rating of “Hold” and a consensus price target of $146.43.

View Our Latest Report on CLX

Clorox Trading Up 0.7 %

Shares of CLX stock opened at $136.64 on Friday. The stock has a market cap of $16.97 billion, a price-to-earnings ratio of 70.80, a PEG ratio of 2.18 and a beta of 0.39. The stock has a 50-day moving average of $137.62 and a 200-day moving average of $144.02. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $169.14.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.38. The company had revenue of $1.81 billion during the quarter, compared to analysts’ expectations of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The business’s quarterly revenue was down 5.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.51 earnings per share. On average, equities research analysts forecast that The Clorox Company will post 5.91 earnings per share for the current year.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.